ID

27614

Beschreibung

Postprandial Effects of Walnut Components Versus Whole Walnuts on Cardiovascular Disease (CVD) Risk Reduction; ODM derived from: https://clinicaltrials.gov/show/NCT00938340

Link

https://clinicaltrials.gov/show/NCT00938340

Stichworte

Versionen (1)
  1. 22.11.17 22.11.17 -
Rechteinhaber

See clinicaltrials.gov

Hochgeladen am

22. November 2017

DOI

Für eine Beantragung loggen Sie sich ein.

Lizenz

Creative Commons BY 4.0
Modell Kommentare :

Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.

Zurück zu Modell Kommentaren
Itemgroup Kommentare für :

Item Kommentare für :

Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.

Eligibility Cardiovascular Disease NCT00938340

Englisch

Eligibility Cardiovascular Disease NCT00938340

1 Formulare  
Inclusion Criteria
Beschreibung

Inclusion Criteria

Alias
UMLS CUI
C1512693
age 21 - 60 years
Beschreibung

Age

Datentyp

boolean

Alias
UMLS CUI [1]
C0001779
body mass index 25-39 kg/m2
Beschreibung

Body mass index

Datentyp

boolean

Alias
UMLS CUI [1]
C1305855
ldl cholesterol >110 mg/dl
Beschreibung

Low density lipoprotein cholesterol measurement

Datentyp

boolean

Alias
UMLS CUI [1]
C0202117
<95 percentile for age and gender for both (based on nhanes data)
Beschreibung

Age Percentile | Gender Percentile

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0001779
UMLS CUI [1,2]
C1264641
UMLS CUI [2,1]
C0079399
UMLS CUI [2,2]
C1264641
tg < 350 mg/dl
Beschreibung

Serum Triglyceride Measurement

Datentyp

boolean

Alias
UMLS CUI [1]
C0542495
Exclusion Criteria
Beschreibung

Exclusion Criteria

Alias
UMLS CUI
C0680251
high alcohol consumption > 21 units/week (female subjects) or > 28 units/week (male subjects)
Beschreibung

Alcohol consumption High U/week | Gender

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0001948
UMLS CUI [1,2]
C0205250
UMLS CUI [1,3]
C0560588
UMLS CUI [2]
C0079399
intake of vitamin and mineral supplements within the past 3 weeks or unwillingness to discontinue for 3 weeks prior to screening and for entire study.
Beschreibung

Vitamin supplement | Mineral supplements | Vitamin supplement Discontinue Unwilling | Mineral supplements Discontinue Unwilling

Datentyp

boolean

Alias
UMLS CUI [1]
C0681579
UMLS CUI [2]
C0556112
UMLS CUI [3,1]
C0681579
UMLS CUI [3,2]
C1444662
UMLS CUI [3,3]
C0558080
UMLS CUI [4,1]
C0556112
UMLS CUI [4,2]
C1444662
UMLS CUI [4,3]
C0558080
use of prescription cholesterol-lowering or blood pressure-lowering medications during the study
Beschreibung

Anticholesteremic Agents Prescription | Antihypertensive Agents Prescription

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0003277
UMLS CUI [1,2]
C0033080
UMLS CUI [2,1]
C0003364
UMLS CUI [2,2]
C0033080
intake of other putative cholesterol-lowering supplements (excl. psyllium, fish oil capsules, soy lecithin, phytoestrogens)
Beschreibung

Anticholesteremic Agents | Psyllium Exclusive | Fish Oil Oral Capsule Exclusive | Soy Lecithin Exclusive | Phytoestrogens Exclusive

Datentyp

boolean

Alias
UMLS CUI [1]
C0003277
UMLS CUI [2,1]
C0033979
UMLS CUI [2,2]
C1548966
UMLS CUI [3,1]
C1617119
UMLS CUI [3,2]
C1548966
UMLS CUI [4,1]
C0872912
UMLS CUI [4,2]
C1548966
UMLS CUI [5,1]
C0071011
UMLS CUI [5,2]
C1548966
intake of anti-inflammatory medications (containing aspirin or nsaids) on a regular basis or if an acute intake, within 48 hours of a test day
Beschreibung

Anti-Inflammatory Agents Containing Aspirin | Anti-Inflammatory Agents Containing NSAIDs

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0003209
UMLS CUI [1,2]
C0332256
UMLS CUI [1,3]
C0004057
UMLS CUI [2,1]
C0003209
UMLS CUI [2,2]
C0332256
UMLS CUI [2,3]
C0003211
diabetes, liver, kidney, thyroid (unless controlled and stable on replacement medication) or other endocrine disorders from self-reported medical history
Beschreibung

Diabetes Mellitus | Liver diseases | Kidney Diseases | Thyroid Diseases | Exception Disease Controlled | Exception Thyroid Disease Stable | Exception Replacement Medication | Endocrine System Diseases

Datentyp

boolean

Alias
UMLS CUI [1]
C0011849
UMLS CUI [2]
C0023895
UMLS CUI [3]
C0022658
UMLS CUI [4]
C0040128
UMLS CUI [5,1]
C1705847
UMLS CUI [5,2]
C2911690
UMLS CUI [6,1]
C1705847
UMLS CUI [6,2]
C0040128
UMLS CUI [6,3]
C0205360
UMLS CUI [7,1]
C1705847
UMLS CUI [7,2]
C0559956
UMLS CUI [7,3]
C0013227
UMLS CUI [8]
C0014130
treatment with drugs acting on the gut, such as ezetimibe, bile acid-binding resins, orlistat
Beschreibung

Pharmaceutical Preparations Affecting Gut | ezetimibe | Bile-acid Binding Resin | orlistat

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0013227
UMLS CUI [1,2]
C0392760
UMLS CUI [1,3]
C0699819
UMLS CUI [2]
C1142985
UMLS CUI [3]
C2266924
UMLS CUI [4]
C0076275
dietary restrictions such as a medically prescribed diet, or a slimming diet prior to or during the trial
Beschreibung

Restricted diet | Prescribed dietary intake | Slimming diet

Datentyp

boolean

Alias
UMLS CUI [1]
C0425422
UMLS CUI [2]
C1261371
UMLS CUI [3]
C0521973
weight loss or gain of 10% body weight or more during a period of 6 months before pre-study examination.
Beschreibung

Weight decreased Percent of body weight | Weight Gain Percent of body weight

Datentyp

boolean

Alias
UMLS CUI [1,1]
C1262477
UMLS CUI [1,2]
C3476809
UMLS CUI [2,1]
C0043094
UMLS CUI [2,2]
C3476809
blood/plasma donation for reason(s) other than the present study prior to the study (1 month for a male subject or 2 months for a female subject), or during the study
Beschreibung

Blood Donation | Exception Clinical Trial Present

Datentyp

boolean

Alias
UMLS CUI [1]
C0005794
UMLS CUI [2,1]
C1705847
UMLS CUI [2,2]
C0008976
UMLS CUI [2,3]
C0150312
lactation 6 weeks before the start of and during study, pregnant or wishing to become pregnant 3 months before or during the study
Beschreibung

Breast Feeding | Pregnancy | Pregnancy, Planned

Datentyp

boolean

Alias
UMLS CUI [1]
C0006147
UMLS CUI [2]
C0032961
UMLS CUI [3]
C0032992
Zum Seitenanfang zurückkehren

Ähnliche Modelle

Eligibility Cardiovascular Disease NCT00938340

1 Formulare
Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Item Group
C1512693 (UMLS CUI)
Age
Item
age 21 - 60 years
boolean
C0001779 (UMLS CUI [1])
Body mass index
Item
body mass index 25-39 kg/m2
boolean
C1305855 (UMLS CUI [1])
Low density lipoprotein cholesterol measurement
Item
ldl cholesterol >110 mg/dl
boolean
C0202117 (UMLS CUI [1])
Age Percentile | Gender Percentile
Item
<95 percentile for age and gender for both (based on nhanes data)
boolean
C0001779 (UMLS CUI [1,1])
C1264641 (UMLS CUI [1,2])
C0079399 (UMLS CUI [2,1])
C1264641 (UMLS CUI [2,2])
Serum Triglyceride Measurement
Item
tg < 350 mg/dl
boolean
C0542495 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Alcohol consumption High U/week | Gender
Item
high alcohol consumption > 21 units/week (female subjects) or > 28 units/week (male subjects)
boolean
C0001948 (UMLS CUI [1,1])
C0205250 (UMLS CUI [1,2])
C0560588 (UMLS CUI [1,3])
C0079399 (UMLS CUI [2])
Vitamin supplement | Mineral supplements | Vitamin supplement Discontinue Unwilling | Mineral supplements Discontinue Unwilling
Item
intake of vitamin and mineral supplements within the past 3 weeks or unwillingness to discontinue for 3 weeks prior to screening and for entire study.
boolean
C0681579 (UMLS CUI [1])
C0556112 (UMLS CUI [2])
C0681579 (UMLS CUI [3,1])
C1444662 (UMLS CUI [3,2])
C0558080 (UMLS CUI [3,3])
C0556112 (UMLS CUI [4,1])
C1444662 (UMLS CUI [4,2])
C0558080 (UMLS CUI [4,3])
Anticholesteremic Agents Prescription | Antihypertensive Agents Prescription
Item
use of prescription cholesterol-lowering or blood pressure-lowering medications during the study
boolean
C0003277 (UMLS CUI [1,1])
C0033080 (UMLS CUI [1,2])
C0003364 (UMLS CUI [2,1])
C0033080 (UMLS CUI [2,2])
Anticholesteremic Agents | Psyllium Exclusive | Fish Oil Oral Capsule Exclusive | Soy Lecithin Exclusive | Phytoestrogens Exclusive
Item
intake of other putative cholesterol-lowering supplements (excl. psyllium, fish oil capsules, soy lecithin, phytoestrogens)
boolean
C0003277 (UMLS CUI [1])
C0033979 (UMLS CUI [2,1])
C1548966 (UMLS CUI [2,2])
C1617119 (UMLS CUI [3,1])
C1548966 (UMLS CUI [3,2])
C0872912 (UMLS CUI [4,1])
C1548966 (UMLS CUI [4,2])
C0071011 (UMLS CUI [5,1])
C1548966 (UMLS CUI [5,2])
Anti-Inflammatory Agents Containing Aspirin | Anti-Inflammatory Agents Containing NSAIDs
Item
intake of anti-inflammatory medications (containing aspirin or nsaids) on a regular basis or if an acute intake, within 48 hours of a test day
boolean
C0003209 (UMLS CUI [1,1])
C0332256 (UMLS CUI [1,2])
C0004057 (UMLS CUI [1,3])
C0003209 (UMLS CUI [2,1])
C0332256 (UMLS CUI [2,2])
C0003211 (UMLS CUI [2,3])
Diabetes Mellitus | Liver diseases | Kidney Diseases | Thyroid Diseases | Exception Disease Controlled | Exception Thyroid Disease Stable | Exception Replacement Medication | Endocrine System Diseases
Item
diabetes, liver, kidney, thyroid (unless controlled and stable on replacement medication) or other endocrine disorders from self-reported medical history
boolean
C0011849 (UMLS CUI [1])
C0023895 (UMLS CUI [2])
C0022658 (UMLS CUI [3])
C0040128 (UMLS CUI [4])
C1705847 (UMLS CUI [5,1])
C2911690 (UMLS CUI [5,2])
C1705847 (UMLS CUI [6,1])
C0040128 (UMLS CUI [6,2])
C0205360 (UMLS CUI [6,3])
C1705847 (UMLS CUI [7,1])
C0559956 (UMLS CUI [7,2])
C0013227 (UMLS CUI [7,3])
C0014130 (UMLS CUI [8])
Pharmaceutical Preparations Affecting Gut | ezetimibe | Bile-acid Binding Resin | orlistat
Item
treatment with drugs acting on the gut, such as ezetimibe, bile acid-binding resins, orlistat
boolean
C0013227 (UMLS CUI [1,1])
C0392760 (UMLS CUI [1,2])
C0699819 (UMLS CUI [1,3])
C1142985 (UMLS CUI [2])
C2266924 (UMLS CUI [3])
C0076275 (UMLS CUI [4])
Restricted diet | Prescribed dietary intake | Slimming diet
Item
dietary restrictions such as a medically prescribed diet, or a slimming diet prior to or during the trial
boolean
C0425422 (UMLS CUI [1])
C1261371 (UMLS CUI [2])
C0521973 (UMLS CUI [3])
Weight decreased Percent of body weight | Weight Gain Percent of body weight
Item
weight loss or gain of 10% body weight or more during a period of 6 months before pre-study examination.
boolean
C1262477 (UMLS CUI [1,1])
C3476809 (UMLS CUI [1,2])
C0043094 (UMLS CUI [2,1])
C3476809 (UMLS CUI [2,2])
Blood Donation | Exception Clinical Trial Present
Item
blood/plasma donation for reason(s) other than the present study prior to the study (1 month for a male subject or 2 months for a female subject), or during the study
boolean
C0005794 (UMLS CUI [1])
C1705847 (UMLS CUI [2,1])
C0008976 (UMLS CUI [2,2])
C0150312 (UMLS CUI [2,3])
Breast Feeding | Pregnancy | Pregnancy, Planned
Item
lactation 6 weeks before the start of and during study, pregnant or wishing to become pregnant 3 months before or during the study
boolean
C0006147 (UMLS CUI [1])
C0032961 (UMLS CUI [2])
C0032992 (UMLS CUI [3])
Zum Seitenanfang zurückkehren 

Kontakt

Benutzen Sie dieses Formular für Rückmeldungen, Fragen und Verbesserungsvorschläge.

Mit * gekennzeichnete Felder sind notwendig.

Hilfe

Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

Zum Video